{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:51:11Z","timestamp":1774842671968,"version":"3.50.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Deanship of Graduate Studies and Scientific Research at Majmaah University in Saudi Arabia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["3 Biotech"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s13205-024-04093-5","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:04:40Z","timestamp":1727298280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Biological roles of THRAP3, STMN1 and GNA13 in human blood cancer cells"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2242-5638","authenticated-orcid":false,"given":"Suliman A.","family":"Alsagaby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"4093_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4081\/oncol.2019.435","volume":"13","author":"SA Alsagaby","year":"2019","unstructured":"Alsagaby SA (2019) Omics-based insights into therapy failure of pediatric B-lineage acute lymphoblastic leukemia. Oncol Rev 13:150\u2013157","journal-title":"Oncol Rev"},{"key":"4093_CR2","doi-asserted-by":"publisher","first-page":"6633386","DOI":"10.1155\/2021\/6633386","volume":"2021","author":"SA Alsagaby","year":"2021","unstructured":"Alsagaby SA (2021) Molecular insights into the potential of extracellular vesicles released from mesenchymal stem cells and other cells in the therapy of hematologic malignancies. Stem Cells International 2021:6633386","journal-title":"Stem Cells International"},{"key":"4093_CR3","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2147\/IJN.S355408","volume":"17","author":"SA Alsagaby","year":"2022","unstructured":"Alsagaby SA (2022) Transcriptomics-based investigation of molecular mechanisms underlying apoptosis induced by ZnO nanoparticles in human diffuse large B-cell lymphoma. Int J Nanomed 17:2261\u20132281","journal-title":"Int J Nanomed"},{"key":"4093_CR4","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1021\/pr5002803","volume":"13","author":"SA Alsagaby","year":"2014","unstructured":"Alsagaby SA, Khanna S, Hart KW, Pratt G, Fegan C, Pepper C, Brewis IA, Brennan P (2014) Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia. J Proteome Res 13:5051\u20135062","journal-title":"J Proteome Res"},{"key":"4093_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejbt.2021.04.006","volume":"52","author":"SA Alsagaby","year":"2021","unstructured":"Alsagaby SA, Brewis IA, Vijayakumar R, Alhumaydhi FA, Alwashmi AS, Alharbi NK, Al AW, Premanathan M, Pratt G, Fegan C (2021) Proteomics-based identification of cancer-associated proteins in chronic lymphocytic leukaemia. Electron J Biotechnol 52:1\u201312","journal-title":"Electron J Biotechnol"},{"key":"4093_CR6","doi-asserted-by":"publisher","first-page":"17648","DOI":"10.1038\/s41598-022-21546-0","volume":"12","author":"SA Alsagaby","year":"2022","unstructured":"Alsagaby SA, Iqbal D, Ahmad I, Patel H, Mir SA, Madkhali YA, Oyouni AAA, Hawsawi YM, Alhumaydhi FA, Alshehri B (2022) In silico investigations identified Butyl Xanalterate to competently target CK2\u03b1 (CSNK2A1) for therapy of chronic lymphocytic leukemia. Sci Rep 12:17648","journal-title":"Sci Rep"},{"key":"4093_CR7","doi-asserted-by":"crossref","unstructured":"Alsagaby SA, Vijayakumar R, Premanathan M, Mickymaray S, Alturaiki W, Al-Baradie RS, AlGhamdi S, Aziz MA, Alhumaydhi FA, Alzahrani FA (2020) Transcriptomics-based characterization of the toxicity of ZnO nanoparticles against chronic myeloid leukemia cells. International Journal of Nanomedicine 7901\u201321","DOI":"10.2147\/IJN.S261636"},{"key":"4093_CR8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/bjc.2017.76","volume":"116","author":"T Bai","year":"2017","unstructured":"Bai T, Yokobori T, Altan B, Ide M, Mochiki E, Yanai M, Kimura A, Kogure N, Yanoma T, Suzuki M (2017) High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients. Br J Cancer 116:1177\u20131185","journal-title":"Br J Cancer"},{"key":"4093_CR9","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1245\/s10434-017-6083-0","volume":"24","author":"P Bao","year":"2017","unstructured":"Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K (2017) High STMN1 expression is associated with cancer progression and chemo-resistance in lung squamous cell carcinoma. Ann Surg Oncol 24:4017\u20134024","journal-title":"Ann Surg Oncol"},{"key":"4093_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.molcel.2012.01.026","volume":"46","author":"P Beli","year":"2012","unstructured":"Beli P, Lukashchuk N, Wagner SA, Weinert BT, Olsen JV, Baskcomb L, Mann M, Jackson SP, Choudhary C (2012) Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response. Mol Cell 46:212\u2013225","journal-title":"Mol Cell"},{"key":"4093_CR11","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1158\/0008-5472.CAN-08-1217","volume":"68","author":"CP Bracken","year":"2008","unstructured":"Bracken CP, Wall SJ, Barr\u00e9 B, Panov KI, Ajuh PM, Perkins ND (2008) Regulation of cyclin D1 RNA stability by SNIP1. Cancer Res 68:7621\u20137628","journal-title":"Cancer Res"},{"key":"4093_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB (2015) S100 proteins in cancer. Nat Rev Cancer 15:96\u2013109","journal-title":"Nat Rev Cancer"},{"key":"4093_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nrc.2017.121","volume":"18","author":"JA Burger","year":"2018","unstructured":"Burger JA, Wiestner A (2018) Targeting B cell receptor signalling in cancer: preclinical and clinical advances. Nat Rev Cancer 18:148\u2013167","journal-title":"Nat Rev Cancer"},{"key":"4093_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tibs.2006.01.006","volume":"31","author":"SK Calderwood","year":"2006","unstructured":"Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31:164\u2013172","journal-title":"Trends Biochem Sci"},{"key":"4093_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.trecan.2019.04.001","volume":"5","author":"PC Calses","year":"2019","unstructured":"Calses PC, Crawford JJ, Lill JR, Dey A (2019) Hippo pathway in cancer: aberrant regulation and therapeutic opportunities. Trends in Cancer 5:297\u2013307","journal-title":"Trends in Cancer"},{"key":"4093_CR16","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1007\/s13277-015-4088-5","volume":"37","author":"W Chen","year":"2016","unstructured":"Chen W, Zhang L, Wang Y, Sun J, Wang D, Fan S, Ban N, Zhu J, Ji B, Wang Y (2016) Expression of CDC5L is associated with tumor progression in gliomas. Tumor Biol 37:4093\u20134103","journal-title":"Tumor Biol"},{"key":"4093_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/15384101.2023.2170521","volume":"22","author":"C-J Chen","year":"2023","unstructured":"Chen C-J, Huang J-Y, Huang J-Q, Deng J-Y, Shangguan X-H, Chen A-Z, Chen L-T, Wu W-H (2023) Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4. Cell Cycle 22:986\u20131004","journal-title":"Cell Cycle"},{"key":"4093_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T (2016) The gene expression omnibus database. Statis Genom Methods Protoc 1418:93\u2013110","journal-title":"Statis Genom Methods Protoc"},{"key":"4093_CR19","doi-asserted-by":"publisher","first-page":"D472","DOI":"10.1093\/nar\/gkt1102","volume":"42","author":"D Croft","year":"2014","unstructured":"Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, Caudy M, Garapati P, Gillespie M, Kamdar MR (2014) The Reactome pathway knowledgebase. Nucleic Acids Res 42:D472\u2013D477","journal-title":"Nucleic Acids Res"},{"key":"4093_CR20","doi-asserted-by":"crossref","unstructured":"Cui W, Zheng S, Liu Z, Wang W, Cai Y, Bi R, Cao B, Zhou X (2017) PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro. Onco Targets Ther 2239\u201347","DOI":"10.2147\/OTT.S129970"},{"key":"4093_CR21","doi-asserted-by":"publisher","first-page":"80901","DOI":"10.18632\/oncotarget.12646","volume":"7","author":"C D'Alesio","year":"2016","unstructured":"D\u2019Alesio C, Punzi S, Cicalese A, Fornasari L, Furia L, Riva L, Carugo A, Curigliano G, Criscitiello C, Pruneri G (2016) RNAi screens identify CHD4 as an essential gene in breast cancer growth. Oncotarget 7:80901\u201380915","journal-title":"Oncotarget"},{"key":"4093_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fmolb.2018.00080","volume":"5","author":"E El Marabti","year":"2018","unstructured":"El Marabti E, Younis I (2018) The cancer spliceome: reprograming of alternative splicing in cancer. Front Mol Biosci 5:80\u201391","journal-title":"Front Mol Biosci"},{"key":"4093_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7150\/ijbs.20052","volume":"13","author":"M Farhan","year":"2017","unstructured":"Farhan M, Wang H, Gaur U, Little PJ, Xu J, Zheng W (2017) FOXO signaling pathways as therapeutic targets in cancer. Int J Biol Sci 13:815","journal-title":"Int J Biol Sci"},{"key":"4093_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s10495-008-0300-z","volume":"14","author":"A Frenzel","year":"2009","unstructured":"Frenzel A, Grespi F, Chmelewskij W, Villunger A (2009) Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis 14:584\u2013596","journal-title":"Apoptosis"},{"key":"4093_CR25","doi-asserted-by":"publisher","first-page":"D258","DOI":"10.1093\/nar\/gkh036","volume":"32","author":"OC Gene","year":"2004","unstructured":"Gene OC (2004) The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32:D258\u2013D261","journal-title":"Nucleic Acids Res"},{"key":"4093_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2022.13194","volume":"23","author":"CG Gonzalez","year":"2022","unstructured":"Gonzalez CG, Akula S, Burleson M (2022) The role of mediator subunit 12 in tumorigenesis and cancer therapeutics. Oncol Lett 23:1\u20138","journal-title":"Oncol Lett"},{"key":"4093_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9\u201322","journal-title":"Cancer Cell"},{"key":"4093_CR28","first-page":"767","volume":"49","author":"RP Guillerman","year":"2011","unstructured":"Guillerman RP, Voss SD, Parker BR (2011) Leukemia and lymphoma. Radiologic. Clinics 49:767\u2013797","journal-title":"Clinics"},{"key":"4093_CR29","doi-asserted-by":"publisher","first-page":"9951","DOI":"10.1007\/s13277-016-4869-5","volume":"37","author":"X He","year":"2016","unstructured":"He X, Liao Y, Lu W, Xu G, Tong H, Ke J, Wan X (2016) Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma. Tumor Biol 37:9951\u20139958","journal-title":"Tumor Biol"},{"key":"4093_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0022-2836(02)00969-5","volume":"323","author":"LM Iakoucheva","year":"2002","unstructured":"Iakoucheva LM, Brown CJ, Lawson JD, Obradovi\u0107 Z, Dunker AK (2002) Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 323:573\u2013584","journal-title":"J Mol Biol"},{"key":"4093_CR31","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/pmic.201500365","volume":"16","author":"Y Ino","year":"2016","unstructured":"Ino Y, Arakawa N, Ishiguro H, Uemura H, Kubota Y, Hirano H, Toda T (2016) Phosphoproteome analysis demonstrates the potential role of THRAP3 phosphorylation in androgen-independent prostate cancer cell growth. Proteomics 16:1069\u20131078","journal-title":"Proteomics"},{"key":"4093_CR32","first-page":"949","volume":"125","author":"L Jahn","year":"2015","unstructured":"Jahn L, Hombrink P, Hassan C, Kester MGD, van der Steen DM, Hagedoorn RS, Falkenburg JHF, van Veelen PA, Heemskerk MHM (2015) Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b. Blood J Am Soc Hematol 125:949\u2013958","journal-title":"Blood J Am Soc Hematol"},{"key":"4093_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27\u201330","journal-title":"Nucleic Acids Res"},{"key":"4093_CR34","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M (2023) KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res 51:D587\u2013D592","journal-title":"Nucleic Acids Res"},{"key":"4093_CR35","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1080\/21691401.2019.1614017","volume":"47","author":"Y Ke","year":"2019","unstructured":"Ke Y, Al Aboody MS, Alturaiki W, Alsagaby SA, Alfaiz FA, Veeraraghavan VP, Mickymaray S (2019) Photosynthesized gold nanoparticles from Catharanthus roseus induces caspase-mediated apoptosis in cervical cancer cells (HeLa). Artif Cells Nanomed Biotechnol 47:1938\u20131946","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"4093_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntm.2023.100002","volume":"2","author":"X Ke","year":"2023","unstructured":"Ke X, Zhang Q, Zhu P, He H, Yuan J, Ao Q (2023) GNA13 is a new marker for germinal center-derived B cell lymphomas. Nano TransMed 2:100002","journal-title":"Nano TransMed"},{"key":"4093_CR37","doi-asserted-by":"publisher","first-page":"D1301","DOI":"10.1093\/nar\/gkr1074","volume":"40","author":"T Kelder","year":"2012","unstructured":"Kelder T, Van Iersel MP, Hanspers K, Kutmon M, Conklin BR, Evelo CT, Pico AR (2012) WikiPathways: building research communities on biological pathways. Nucleic Acids Res 40:D1301\u2013D1307","journal-title":"Nucleic Acids Res"},{"key":"4093_CR38","doi-asserted-by":"publisher","first-page":"10314","DOI":"10.1073\/pnas.0401366101","volume":"101","author":"BF Krakstad","year":"2004","unstructured":"Krakstad BF, Ardawatia VV, Aragay AM (2004) A role for Galpha12\/Galpha13 in p120ctn regulation. Proc Natl Acad Sci U S A 101:10314\u201310319","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4093_CR39","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1073\/pnas.1305980110","volume":"110","author":"L Lande-Diner","year":"2013","unstructured":"Lande-Diner L, Boyault C, Kim JY, Weitz CJ (2013) A positive feedback loop links circadian clock factor CLOCK-BMAL1 to the basic transcriptional machinery. Proc Natl Acad Sci U S A 110:16021\u201316026","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4093_CR40","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1093\/nar\/gkq017","volume":"38","author":"KM Lee","year":"2010","unstructured":"Lee KM, Hsu IW, Tarn WY (2010) TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA degradation. Nucleic Acids Res 38:3340\u20133350","journal-title":"Nucleic Acids Res"},{"key":"4093_CR41","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.3892\/mmr.2014.2558","volume":"10","author":"J Li","year":"2014","unstructured":"Li J, Kong F, Wu K, Song K, He J, Sun W (2014) miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer. Mol Med Report 10:2613\u20132620","journal-title":"Mol Med Report"},{"key":"4093_CR42","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s12253-015-9930-y","volume":"21","author":"J Li","year":"2015","unstructured":"Li J, Hu G, Kong F, Wu K, Song K, He J, Sun W (2015) Elevated STMN1 expression correlates with poor prognosis in patients with pancreatic ductal adenocarcinoma. Pathol Oncol Res 21:1013\u20131020","journal-title":"Pathol Oncol Res"},{"key":"4093_CR43","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1159\/000475916","volume":"41","author":"J Li","year":"2017","unstructured":"Li J, Zhang N, Zhang R, Sun L, Yu W, Guo W, Gao Y, Li M, Liu W, Liang P (2017a) CDC5L promotes hTERT expression and colorectal tumor growth. Cell Physiol Biochem 41:2475\u20132488","journal-title":"Cell Physiol Biochem"},{"key":"4093_CR44","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/bjc.2017.292","volume":"117","author":"M Li","year":"2017","unstructured":"Li M, Yang J, Zhou W, Ren Y, Wang X, Chen H, Zhang J, Chen J, Sun Y, Cui L (2017b) Activation of an AKT\/FOXM1\/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer. Br J Cancer 117:974\u2013983","journal-title":"Br J Cancer"},{"key":"4093_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/1878-0261.12173","volume":"12","author":"Y Li","year":"2018","unstructured":"Li Y, Li L, Chen M, Yu X, Gu Z, Qiu H, Qin G, Long Q, Fu X, Liu T (2018) MAD 2L2 inhibits colorectal cancer growth by promoting NCOA 3 ubiquitination and degradation. Mol Oncol 12:391\u2013405","journal-title":"Mol Oncol"},{"key":"4093_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1085-0","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, He S, Ma B (2020) Autophagy and autophagy-related proteins in cancer. Mol Cancer 19:1\u201316","journal-title":"Mol Cancer"},{"key":"4093_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3661","volume":"26","author":"K Li","year":"2024","unstructured":"Li K, Dai P, Li J, Liu L, Cheng S, Fang Q, Wu B (2024) AKT\/FOXM1\/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer. J Gene Med 26:e3661","journal-title":"J Gene Med"},{"key":"4093_CR48","doi-asserted-by":"crossref","unstructured":"Li Y, Liang J, Dang H, Zhang R, Chen P, Shao Y (2022) NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways. Endocrine 1\u201310","DOI":"10.21203\/rs.3.rs-254425\/v1"},{"key":"4093_CR49","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1096\/fj.201701355RR","volume":"33","author":"T Liu","year":"2019","unstructured":"Liu T, Liu L, Liu M, Du R, Dang Y, Bai M, Zhang L, Ma F, Yang X, Ning X (2019) MicroRNA-493 targets STMN-1 and promotes hypoxia-induced epithelial cell cycle arrest in G2\/M and renal fibrosis. FASEB J 33:1565\u20131577","journal-title":"FASEB J"},{"key":"4093_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.7150\/ijbs.50810","volume":"17","author":"W Liu","year":"2021","unstructured":"Liu W, Wang C, Wang S, Zeng K, Wei S, Sun N, Sun G, Wang M, Zou R, Liu W (2021) PRPF6 promotes androgen receptor\/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells. Int J Biol Sci 17:188\u2013203","journal-title":"Int J Biol Sci"},{"key":"4093_CR51","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, Hasz R, Walters G, Garcia F, Young N (2013) The genotype-tissue expression (GTEx) project. Nat Genet 45:580\u2013585","journal-title":"Nat Genet"},{"key":"4093_CR52","doi-asserted-by":"crossref","unstructured":"Mburu W, Devesa SS, Check D, Shiels MS, Mbulaiteye SM (2023) Incidence of Burkitt lymphoma in the United States during 2000 to 2019. Int. J. Cancer 1182\u201391","DOI":"10.1002\/ijc.34618"},{"key":"4093_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004558","volume":"10","author":"MB Menon","year":"2014","unstructured":"Menon MB, Sawada A, Chaturvedi A, Mishra P, Schuster-Gossler K, Galla M, Schambach A, Gossler A, F\u00f6rster R, Heuser M (2014) Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis. PLoS Genet 10:e1004558","journal-title":"PLoS Genet"},{"key":"4093_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.gde.2008.01.020","volume":"18","author":"WE Naugler","year":"2008","unstructured":"Naugler WE, Karin M (2008) NF-\u03baB and cancer\u2014identifying targets and mechanisms. Curr Opin Genet Dev 18:19\u201326","journal-title":"Curr Opin Genet Dev"},{"key":"4093_CR55","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ (2021) Advances in acute myeloid leukemia. BMJ 375:2026","journal-title":"BMJ"},{"key":"4093_CR56","doi-asserted-by":"crossref","unstructured":"Nie L, Zhang C, Song H, Zhao Q, Cheng L, Zhang P, Yang X (2022) Overexpression of stathmin 1 predicts poor prognosis and promotes cancer cell proliferation and migration in ovarian cancer. Dis. Markers 2022","DOI":"10.1155\/2022\/3554100"},{"key":"4093_CR57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","volume":"17","author":"T Otto","year":"2017","unstructured":"Otto T, Sicinski P (2017) Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer 17:93\u2013115","journal-title":"Nat Rev Cancer"},{"key":"4093_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2020.12.026","volume":"501","author":"Z Pan","year":"2021","unstructured":"Pan Z, Fang Q, Li L, Zhang Y, Xu T, Liu Y, Zheng X, Tan Z, Huang P, Ge M (2021) HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1. Cancer Lett 501:31\u201342","journal-title":"Cancer Lett"},{"key":"4093_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/03936155221106799","volume":"37","author":"Z Pan","year":"2022","unstructured":"Pan Z, Zheng Z, Ye W, Chen C, Ye S (2022) Overexpression of GNA13 correlates with poor prognosis in esophageal squamous cell carcinoma after esophagectomy. Int J Biol Markers 37:289\u2013295","journal-title":"Int J Biol Markers"},{"key":"4093_CR60","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1080\/10428194.2019.1605071","volume":"60","author":"H Rafei","year":"2019","unstructured":"Rafei H, Kantarjian HM, Jabbour EJ (2019) Recent advances in the treatment of acute lymphoblastic leukemia. Leuk Lymphoma 60:2606\u20132621","journal-title":"Leuk Lymphoma"},{"key":"4093_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-015-0337-x","volume":"14","author":"SAK Rasheed","year":"2015","unstructured":"Rasheed SAK, Teo CR, Beillard EJ, Voorhoeve PM, Zhou W, Ghosh S, Casey PJ (2015) MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells. Mol Cancer 14:1\u201310","journal-title":"Mol Cancer"},{"key":"4093_CR62","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s41388-017-0038-6","volume":"37","author":"SAK Rasheed","year":"2018","unstructured":"Rasheed SAK, Leong HS, Lakshmanan M, Raju A, Dadlani D, Chong F-T, Shannon NB, Rajarethinam R, Skanthakumar T, Tan EY (2018) GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers. Oncogene 37:1340\u20131353","journal-title":"Oncogene"},{"key":"4093_CR63","doi-asserted-by":"publisher","first-page":"W83","DOI":"10.1093\/nar\/gkw199","volume":"44","author":"J Reimand","year":"2016","unstructured":"Reimand J, Arak T, Adler P, Kolberg L, Reisberg S, Peterson H, Vilo J (2016) g:Profiler\u2014a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res 44:W83\u2013W89","journal-title":"Nucleic Acids Res"},{"key":"4093_CR64","doi-asserted-by":"crossref","unstructured":"SEER (2024) Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969\u20132022) (http:\/\/www.seer.cancer.gov\/popdata), National Cancer Institute, DCCPS, Surveillance Research Program, released March 2024","DOI":"10.1093\/jncimonographs\/lgae033"},{"key":"4093_CR65","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland KR, Armitage JO, Hancock BW (2012) Non-hodgkin lymphoma. The Lancet 380:848\u2013857","journal-title":"The Lancet"},{"key":"4093_CR66","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504","journal-title":"Genome Res"},{"key":"4093_CR67","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/00365521.2024.2318363","volume":"59","author":"L Shi","year":"2024","unstructured":"Shi L, Luo B, Deng L, Zhang Q, Li Y, Sun D, Zhang H, Zhuang L (2024) The lncRNA TRG-AS1 promotes the growth of colorectal cancer cells through the regulation of P2RY10\/GNA13. Scand J Gastroenterol 59:710\u2013721","journal-title":"Scand J Gastroenterol"},{"key":"4093_CR68","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/PAS.0000000000000969","volume":"42","author":"J Shimono","year":"2018","unstructured":"Shimono J, Miyoshi H, Yoshida N, Kato T, Sato K, Sugio T, Miyawaki K, Kurita D, Sasaki Y, Kawamoto K (2018) Analysis of GNA13 protein in follicular lymphoma and its association with poor prognosis. Am J Surg Pathol 42:1466","journal-title":"Am J Surg Pathol"},{"key":"4093_CR69","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.4103\/jfmpc.jfmpc_1037_19","volume":"9","author":"R Singh","year":"2020","unstructured":"Singh R, Shaik S, Negi BS, Rajguru JP, Patil PB, Parihar AS, Sharma U (2020) Non-Hodgkin\u2019s lymphoma: a review. J Fam Med Prim Care 9:1834\u20131840","journal-title":"J Fam Med Prim Care"},{"key":"4093_CR70","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1111\/cas.14595","volume":"111","author":"H Song","year":"2020","unstructured":"Song H, Sun N, Lin L, Wei S, Zeng K, Liu W, Wang C, Zhong X, Wang M, Wang S (2020) Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma. Cancer Sci 111:3665\u20133678","journal-title":"Cancer Sci"},{"key":"4093_CR71","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47:D607\u2013D613","journal-title":"Nucleic Acids Res"},{"key":"4093_CR72","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98\u2013W102","journal-title":"Nucleic Acids Res"},{"key":"4093_CR73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijms25010010","volume":"25","author":"A Tkachenko","year":"2023","unstructured":"Tkachenko A, Kupcova K, Havranek O (2023) B-cell receptor signaling and beyond: the role of Ig\u03b1 (CD79a)\/Ig\u03b2 (CD79b) in normal and malignant B cells. Int J Mol Sci 25:10","journal-title":"Int J Mol Sci"},{"key":"4093_CR74","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s10637-021-01197-0","volume":"40","author":"HP Vicari","year":"2022","unstructured":"Vicari HP, Coelho-Silva JL, Pereira-Martins DA, Lucena-Araujo AR, Lima K, Lipreri da Silva JC, Scheucher PS, Koury LC, de Melo RA, Bittencourt R (2022) STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells. Invest New Drugs 40:438\u2013452","journal-title":"Invest New Drugs"},{"key":"4093_CR75","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.1093\/nar\/gkx1046","volume":"45","author":"J Vohhodina","year":"2017","unstructured":"Vohhodina J, Barros EM, Savage AL, Liberante FG, Manti L, Bankhead P, Cosgrove N, Madden AF, Harkin DP, Savage KI (2017) The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export. Nucleic Acids Res 45:12816\u201312833","journal-title":"Nucleic Acids Res"},{"key":"4093_CR76","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.ajpath.2017.04.009","volume":"187","author":"J Wang","year":"2017","unstructured":"Wang J, Xu-Monette ZY, Jabbar KJ, Shen Q, Manyam GC, Tzankov A, Visco C, Wang J, Montes-Moreno S, Dybk\u00e6r K (2017) AKT hyperactivation and the potential of AKT-targeted therapy in diffuse large B-cell lymphoma. Am J Pathol 187:1700\u20131716","journal-title":"Am J Pathol"},{"key":"4093_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-020-0113-2","volume":"5","author":"L Wang","year":"2020","unstructured":"Wang L, Qin W, Huo Y-J, Li X, Shi Q, Rasko JEJ, Janin A, Zhao W-L (2020) Advances in targeted therapy for malignant lymphoma. Signal Transduct Target Ther 5:15","journal-title":"Signal Transduct Target Ther"},{"key":"4093_CR78","doi-asserted-by":"publisher","first-page":"275","DOI":"10.32604\/or.2022.03561","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang H, Zhou Y, Zhang S, Qi Y, Wang M (2021) PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16\/CEBPB\/GATA3 axis. Oncol Res 29:275\u2013289","journal-title":"Oncol Res"},{"key":"4093_CR79","first-page":"1","volume":"40","author":"L Wang","year":"2023","unstructured":"Wang L, Cao J, Tao J, Liang Y (2023) STMN1 promotes cell malignancy and bortezomib resistance of multiple myeloma cell lines via PI3K\/AKT signaling. Expert Opin Drug Saf 40:1\u201310","journal-title":"Expert Opin Drug Saf"},{"key":"4093_CR80","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14740338.2023.2251384","volume":"23","author":"L Wang","year":"2024","unstructured":"Wang L, Cao J, Tao J, Liang Y (2024a) STMN1 promotes cell malignancy and bortezomib resistance of multiple myeloma cell lines via PI3K\/AKT signaling. Expert Opin Drug Saf 23:277\u2013286","journal-title":"Expert Opin Drug Saf"},{"key":"4093_CR81","doi-asserted-by":"publisher","first-page":"1277541","DOI":"10.3389\/fgene.2024.1277541","volume":"15","author":"Y-P Wang","year":"2024","unstructured":"Wang Y-P, Ma C, Yang X-K, Zhang N, Sun Z-G (2024b) Pan-cancer and single-cell analysis reveal THRAP3 as a prognostic and immunological biomarker for multiple cancer types. Front Genet 15:1277541","journal-title":"Front Genet"},{"key":"4093_CR82","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM (2013) The cancer genome atlas pan-cancer analysis project. Nat Genet 45:1113\u20131120","journal-title":"Nat Genet"},{"key":"4093_CR83","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.blre.2018.03.005","volume":"32","author":"JC Wight","year":"2018","unstructured":"Wight JC, Chong G, Grigg AP, Hawkes EA (2018) Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Rev 32:400\u2013415","journal-title":"Blood Rev"},{"key":"4093_CR84","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.3390\/ijms25137162","volume":"25","author":"D Wu","year":"2024","unstructured":"Wu D, Casey PJ (2024) GPCR-G\u03b113 involvement in mitochondrial function, oxidative stress, and prostate cancer. Int J Mol Sci 25:7162","journal-title":"Int J Mol Sci"},{"key":"4093_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.994440","volume":"9","author":"J Wu","year":"2022","unstructured":"Wu J, Lu F, Yu B, Wang W, Ye X (2022) The oncogenic role of SNRPB in human tumors: a pan-cancer analysis. Front Mol Biosci 9:994440","journal-title":"Front Mol Biosci"},{"key":"4093_CR86","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.ccell.2017.04.005","volume":"31","author":"L Xia","year":"2017","unstructured":"Xia L, Huang W, Bellani M, Seidman MM, Wu K, Fan D, Nie Y, Cai Y, Zhang YW, Yu L-R (2017) CHD4 has oncogenic functions in initiating and maintaining epigenetic suppression of multiple tumor suppressor genes. Cancer Cell 31:653\u2013668","journal-title":"Cancer Cell"},{"key":"4093_CR87","doi-asserted-by":"publisher","first-page":"35948","DOI":"10.1038\/srep35948","volume":"6","author":"Y Xu","year":"2016","unstructured":"Xu Y, Rong J, Duan S, Chen C, Li Y, Peng B, Yi B, Zheng Z, Gao Y, Wang K (2016) High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma. Sci Rep 6:35948","journal-title":"Sci Rep"},{"key":"4093_CR88","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12885-020-06762-z","volume":"20","author":"N Xu","year":"2020","unstructured":"Xu N, Liu F, Wu S, Ye M, Ge H, Zhang M, Song Y, Tong L, Zhou J, Bai C (2020) CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA\/ROCK pathway by regulating PHF5A. BMC Cancer 20:262","journal-title":"BMC Cancer"},{"key":"4093_CR89","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbrc.2016.04.048","volume":"473","author":"B Yuan","year":"2016","unstructured":"Yuan B, Cui J, Wang W, Deng K (2016) G\u03b112\/13 signaling promotes cervical cancer invasion through the RhoA\/ROCK-JNK signaling axis. Biochem Biophys Res Commun 473:1240\u20131246","journal-title":"Biochem Biophys Res Commun"},{"key":"4093_CR90","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.7150\/ijbs.84738","volume":"20","author":"L Zeng","year":"2024","unstructured":"Zeng L, Lyu X, Yuan J, Chen Y, Wen H, Zhang L, Shi J, Liu B, Li W, Yang S (2024) STMN1 promotes tumor metastasis in non-small cell lung cancer through microtubule-dependent and nonmicrotubule-dependent pathways. Int J Biol Sci 20:1509","journal-title":"Int J Biol Sci"},{"key":"4093_CR91","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.18632\/oncotarget.6780","volume":"7","author":"J-X Zhang","year":"2016","unstructured":"Zhang J-X, Yun M, Xu Y, Chen J-W, Weng H-W, Zheng Z-S, Chen C, Xie D, Ye S (2016) GNA13 as a prognostic factor and mediator of gastric cancer progression. Oncotarget 7:4414","journal-title":"Oncotarget"},{"key":"4093_CR92","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1002\/cam4.1783","volume":"7","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Tan X, Luo J, Cui B, Lei S, Si Z, Shen L, Yao H (2018) GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-\u03baB signaling pathway in colorectal cancer cells. Cancer Med 7:5611\u20135620","journal-title":"Cancer Med"},{"key":"4093_CR93","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/cas.14262","volume":"111","author":"R Zhang","year":"2020","unstructured":"Zhang R, Gao X, Zuo J, Hu B, Yang J, Zhao J, Chen J (2020a) STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Cancer Sci 111:406\u2013417","journal-title":"Cancer Sci"},{"key":"4093_CR94","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/cncr.32672","volume":"126","author":"S Zhang","year":"2020","unstructured":"Zhang S, O\u2019Regan R, Xu W (2020b) The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics. Cancer 126:939\u2013948","journal-title":"Cancer"},{"key":"4093_CR95","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7150\/jca.32850","volume":"11","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Mao W, Wang L, Liu M, Zhang W, Wu Y, Zhang J, Mao S, Geng J, Yao X (2020c) Depletion of CDC5L inhibits bladder cancer tumorigenesis. J Cancer 11:353\u2013363","journal-title":"J Cancer"},{"key":"4093_CR96","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101706R","volume":"36","author":"L Zhou","year":"2022","unstructured":"Zhou L, Li H, Sun S, Zhang T, Yu Y, Xu L, Wang M (2022) Thrap3 promotes osteogenesis by inhibiting the degradation of Runx2. FASEB J 36:e22231","journal-title":"FASEB J"},{"key":"4093_CR97","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/CBM-181675","volume":"23","author":"L Zhu","year":"2018","unstructured":"Zhu L, Chen Y, Nie K, Xiao Y, Yu H (2018) MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1. Cancer Biomark 23:301\u2013309","journal-title":"Cancer Biomark"},{"key":"4093_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109948","volume":"125","author":"L Zhu","year":"2020","unstructured":"Zhu L, Zhang X, Sun Z (2020) SNRPB promotes cervical cancer progression through repressing p53 expression. Biomed Pharmacother 125:109948","journal-title":"Biomed Pharmacother"}],"container-title":["3 Biotech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-024-04093-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13205-024-04093-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-024-04093-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:10:51Z","timestamp":1728493851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13205-024-04093-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["4093"],"URL":"https:\/\/doi.org\/10.1007\/s13205-024-04093-5","relation":{},"ISSN":["2190-572X","2190-5738"],"issn-type":[{"value":"2190-572X","type":"print"},{"value":"2190-5738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"248"}}